Palomba, Stefano <br/><br/>
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.  [electronic resource] 

 -  Fertility and sterility  Feb 2004 
 - 476-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Letter; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/j.fertnstert.2003.07.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alendronate--administration & dosage<br/>Bone Density--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Estradiol--therapeutic use<br/>Estriol--therapeutic use<br/>Estrogen Replacement Therapy<br/>Female<br/>Femur<br/>Half-Life<br/>Humans<br/>Hysterectomy<br/>Lumbar Vertebrae<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Placebos